212Pb-DOTAMTATE showed “unexpectedly good” outcomes among those with gastroenteropancreatic neuroendocrine tumors, said Mary Maluccio, MD, MPH, FACS.
Mary Maluccio, MD, MPH, FACS
Advertisement
Articles by Mary Maluccio, MD, MPH, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
2
Novel Intratumoral Formulation Shows Responses/Safety in Metastatic Cancers
3
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
4
Matched donor allogeneic CAR T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion
5
